ZA200603542B - Oral formulations of desoxypeganine and uses thereof - Google Patents
Oral formulations of desoxypeganine and uses thereofInfo
- Publication number
- ZA200603542B ZA200603542B ZA200603542A ZA200603542A ZA200603542B ZA 200603542 B ZA200603542 B ZA 200603542B ZA 200603542 A ZA200603542 A ZA 200603542A ZA 200603542 A ZA200603542 A ZA 200603542A ZA 200603542 B ZA200603542 B ZA 200603542B
- Authority
- ZA
- South Africa
- Prior art keywords
- desoxypeganine
- oral formulations
- formulations
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10354894A DE10354894A1 (de) | 2003-11-24 | 2003-11-24 | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200603542B true ZA200603542B (en) | 2007-02-28 |
Family
ID=34638177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200603542A ZA200603542B (en) | 2003-11-24 | 2006-05-05 | Oral formulations of desoxypeganine and uses thereof |
Country Status (20)
Country | Link |
---|---|
US (1) | US20070155774A1 (de) |
EP (1) | EP1827402A1 (de) |
JP (1) | JP2007512270A (de) |
KR (1) | KR20060123194A (de) |
CN (1) | CN1886137A (de) |
AR (1) | AR046665A1 (de) |
AU (1) | AU2004294690B2 (de) |
BR (1) | BRPI0416415A (de) |
CA (1) | CA2546950A1 (de) |
DE (1) | DE10354894A1 (de) |
EA (1) | EA008945B1 (de) |
IL (1) | IL175746A0 (de) |
MX (1) | MXPA06005733A (de) |
MY (1) | MY141008A (de) |
NO (1) | NO20062668L (de) |
NZ (1) | NZ547282A (de) |
TW (1) | TW200526223A (de) |
UA (1) | UA87291C2 (de) |
WO (1) | WO2005053698A1 (de) |
ZA (1) | ZA200603542B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE037508T2 (hu) * | 2003-07-24 | 2018-09-28 | Glaxosmithkline Llc | Szájban oldódó filmek |
CA2640243C (en) * | 2006-02-17 | 2015-08-18 | Novartis Ag | Disintegrable oral films |
DE102006027792A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | Antidepressiva-Kombinations-Wafer |
DE102006027791A1 (de) * | 2006-06-16 | 2007-12-20 | Lts Lohmann Therapie-Systeme Ag | AchE-NMDA-Kombinationswafer |
CA2817982C (en) * | 2010-11-15 | 2020-06-30 | The Regents Of The University Of Michigan | Controlled release mucoadhesive systems |
AU2012385956B2 (en) | 2012-07-23 | 2017-03-30 | Crayola, Llc | Dissolvable films and methods of using the same |
DE102017127452A1 (de) * | 2017-11-21 | 2019-05-23 | Lts Lohmann Therapie-Systeme Ag | Wasserlösliche Polymerklebschichten |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN142428B (de) * | 1974-07-05 | 1977-07-09 | Schering Ag | |
CH653550A5 (de) * | 1981-10-20 | 1986-01-15 | Sandoz Ag | Pharmazeutische zusammensetzung zur verzoegerten freigabe eines medikamentes im mundbereich. |
JPS6393717A (ja) * | 1986-10-09 | 1988-04-25 | Sekisui Chem Co Ltd | 口腔粘膜用粘着剤もしくは接着剤 |
EP0386960A3 (de) * | 1989-03-07 | 1991-10-23 | American Cyanamid Company | Pharmazeutische Zusammensetzungen zur Verwendung als Wirkstoffabgabevehikel und/oder als Wundverband |
DE4018247A1 (de) * | 1990-06-07 | 1991-12-12 | Lohmann Therapie Syst Lts | Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen |
EP0515301A3 (en) * | 1991-05-14 | 1993-06-16 | Ernir Snorrason | Improvements in benzodiazepine treatment by cholinesterterase inhibitors |
SE9504537D0 (sv) * | 1995-12-19 | 1995-12-19 | Jan Hedner | Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet |
DE19646392A1 (de) * | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
US6596298B2 (en) * | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
DE19906977C1 (de) * | 1999-02-19 | 2000-06-15 | Lohmann Therapie Syst Lts | Desoxypeganin-TTS und seine Verwendung |
DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
DE19906974C2 (de) * | 1999-02-19 | 2003-10-09 | Lohmann Therapie Syst Lts | Verwendung von Desoxypeganin zur Behandlung des Alkoholismus |
DE10018834A1 (de) * | 2000-04-15 | 2001-10-25 | Lohmann Therapie Syst Lts | Transdermale oder transmucosale Darreichungsformen mit einer nicotinhaltigen Wirkstoffkombination zur Raucherentwöhnung |
US20020151467A1 (en) * | 2000-12-21 | 2002-10-17 | Leung Frank K. | Methods and compositions for oral insulin delivery |
DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
DE10129265A1 (de) * | 2001-06-18 | 2003-01-02 | Hf Arzneimittelforsch Gmbh | Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie |
DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
DE10338544B4 (de) * | 2003-08-19 | 2017-08-31 | Janssen Pharmaceutica N.V. | Buccale Formulierungen des Galanthamins und deren Anwendungen |
-
2003
- 2003-11-24 DE DE10354894A patent/DE10354894A1/de not_active Withdrawn
-
2004
- 2004-11-08 CN CNA2004800347435A patent/CN1886137A/zh active Pending
- 2004-11-08 NZ NZ547282A patent/NZ547282A/en unknown
- 2004-11-08 MX MXPA06005733A patent/MXPA06005733A/es active IP Right Grant
- 2004-11-08 BR BRPI0416415-6A patent/BRPI0416415A/pt not_active IP Right Cessation
- 2004-11-08 AU AU2004294690A patent/AU2004294690B2/en not_active Ceased
- 2004-11-08 EP EP04797702A patent/EP1827402A1/de not_active Withdrawn
- 2004-11-08 CA CA002546950A patent/CA2546950A1/en not_active Abandoned
- 2004-11-08 UA UAA200605675A patent/UA87291C2/ru unknown
- 2004-11-08 EA EA200601015A patent/EA008945B1/ru not_active IP Right Cessation
- 2004-11-08 WO PCT/EP2004/012606 patent/WO2005053698A1/de active Application Filing
- 2004-11-08 US US10/580,485 patent/US20070155774A1/en not_active Abandoned
- 2004-11-08 JP JP2006540236A patent/JP2007512270A/ja active Pending
- 2004-11-08 KR KR1020067010114A patent/KR20060123194A/ko not_active Application Discontinuation
- 2004-11-17 TW TW093135211A patent/TW200526223A/zh unknown
- 2004-11-23 MY MYPI20044848A patent/MY141008A/en unknown
- 2004-11-24 AR ARP040104345A patent/AR046665A1/es unknown
-
2006
- 2006-05-05 ZA ZA200603542A patent/ZA200603542B/xx unknown
- 2006-05-18 IL IL175746A patent/IL175746A0/en unknown
- 2006-06-09 NO NO20062668A patent/NO20062668L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR046665A1 (es) | 2005-12-14 |
CA2546950A1 (en) | 2005-06-16 |
UA87291C2 (ru) | 2009-07-10 |
NZ547282A (en) | 2009-10-30 |
WO2005053698A1 (de) | 2005-06-16 |
BRPI0416415A (pt) | 2007-05-08 |
TW200526223A (en) | 2005-08-16 |
IL175746A0 (en) | 2008-04-13 |
EP1827402A1 (de) | 2007-09-05 |
EA200601015A1 (ru) | 2006-10-27 |
NO20062668L (no) | 2006-06-09 |
AU2004294690A1 (en) | 2005-06-16 |
AU2004294690B2 (en) | 2010-04-08 |
KR20060123194A (ko) | 2006-12-01 |
EA008945B1 (ru) | 2007-10-26 |
MXPA06005733A (es) | 2006-08-17 |
JP2007512270A (ja) | 2007-05-17 |
MY141008A (en) | 2010-02-12 |
DE10354894A1 (de) | 2005-07-07 |
CN1886137A (zh) | 2006-12-27 |
US20070155774A1 (en) | 2007-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1134023A1 (en) | Oral and personal care compositions and methods | |
AU2003259735A8 (en) | Small-mer compositions and methods of use | |
EP1701691A4 (de) | Verfahren und zusammensetzungen für die mundhygiene | |
HK1164133A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
EP1551376A4 (de) | Immunomodulatorische zusammensetzungen, herstellungsverfahren und verwendungsverfahren dafür | |
HK1079710A1 (zh) | 口腔護理套件和組合物 | |
PL1615622T3 (pl) | Preparaty doksycyklin do jednorazowego dziennego podawania | |
AU2003267644A8 (en) | Dental compositions and methods | |
HK1091727A1 (en) | Nasal pharmaceutical formulations and methods of using the same | |
EP1594544A4 (de) | Orale zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und anwendungsverfahren dafür | |
AU2003299441A8 (en) | Nf-hev compositions and methods of use | |
IL166337A0 (en) | Oral administration of calctionin | |
IL175746A0 (en) | Oral formulations of desoxypeganine and uses thereof | |
EP1663255A4 (de) | Withanamid und withanolid-zusammensetzungen und anwendungsverfahren dafür | |
PL378269A1 (pl) | Kompozycje do pielęgnacji jamy ustnej i sposoby | |
GB0202900D0 (en) | Novel formulations of drugs | |
HK1090519A1 (en) | Combinations of vasoprotective agents and formulations containing them | |
AU2003239868A8 (en) | Sunscreen compositions and methods of use thereof | |
EP1625141A4 (de) | Zusammensetzungen auf basis von grp94 und verfahren zu deren anwendung | |
GB0325383D0 (en) | Oral formulations | |
EP1583557A4 (de) | Vakzine-zusammensetzungen und verfahren | |
AU2003294684A8 (en) | Ketoprofen compositions and methods of making them | |
EP1534293A4 (de) | Entzündungshemmende zusammensetzungen und anwendungsverfahren | |
EP1682088A4 (de) | Orale mikroemulsionszusammensetzung mit biphenyldimethyldicarboxylat und silybin | |
GB0327050D0 (en) | Therapeutic methods compositions and uses |